Patents Assigned to Resverlogix Corporation
  • Compounds for the prevention and treatment of cardiovascular diseases
    Patent number: 8053440
    Abstract: The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
    Type: Grant
    Filed: February 1, 2007
    Date of Patent: November 8, 2011
    Assignee: Resverlogix Corporation
    Inventor: Henrik C. Hansen
  • Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
    Patent number: 7846915
    Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: December 7, 2010
    Assignee: Resverlogix Corporation
    Inventors: Norman C. W. Wong, Joseph E. L. Tucker, Henrik C. Hansen, Fabrizio S. Chiacchia, David McCaffrey